These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

821 related articles for article (PubMed ID: 22653783)

  • 1. Sildenafil reduces respiratory muscle weakness and fibrosis in the mdx mouse model of Duchenne muscular dystrophy.
    Percival JM; Whitehead NP; Adams ME; Adamo CM; Beavo JA; Froehner SC
    J Pathol; 2012 Sep; 228(1):77-87. PubMed ID: 22653783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sildenafil reverses cardiac dysfunction in the mdx mouse model of Duchenne muscular dystrophy.
    Adamo CM; Dai DF; Percival JM; Minami E; Willis MS; Patrucco E; Froehner SC; Beavo JA
    Proc Natl Acad Sci U S A; 2010 Nov; 107(44):19079-83. PubMed ID: 20956307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphodiesterase 4 inhibitor and phosphodiesterase 5 inhibitor combination therapy has antifibrotic and anti-inflammatory effects in mdx mice with Duchenne muscular dystrophy.
    Nio Y; Tanaka M; Hirozane Y; Muraki Y; Okawara M; Hazama M; Matsuo T
    FASEB J; 2017 Dec; 31(12):5307-5320. PubMed ID: 28798156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of PDE5 inhibition on dystrophic muscle following an acute bout of downhill running and endurance training.
    Batra A; Vohra RS; Chrzanowski SM; Hammers DW; Lott DJ; Vandenborne K; Walter GA; Forbes SC
    J Appl Physiol (1985); 2019 Jun; 126(6):1737-1745. PubMed ID: 30946638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic N-acetyl cysteine treatment does not improve respiratory system performance in the mdx mouse model of Duchenne muscular dystrophy.
    Maxwell MN; Marullo AL; Valverde-Pérez E; Slyne AD; Murphy BT; O'Halloran KD
    Exp Physiol; 2024 Aug; 109(8):1370-1384. PubMed ID: 38867461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The slow-release adiponectin analog ALY688-SR modifies early-stage disease development in the D2.
    Bellissimo CA; Gandhi S; Castellani LN; Murugathasan M; Delfinis LJ; Thuhan A; Garibotti MC; Seo Y; Rebalka IA; Hsu HH; Sweeney G; Hawke TJ; Abdul-Sater AA; Perry CGR
    Am J Physiol Cell Physiol; 2024 Apr; 326(4):C1011-C1026. PubMed ID: 38145301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PDE5 inhibition alleviates functional muscle ischemia in boys with Duchenne muscular dystrophy.
    Nelson MD; Rader F; Tang X; Tavyev J; Nelson SF; Miceli MC; Elashoff RM; Sweeney HL; Victor RG
    Neurology; 2014 Jun; 82(23):2085-91. PubMed ID: 24808022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dystrophic muscle improvement in zebrafish via increased heme oxygenase signaling.
    Kawahara G; Gasperini MJ; Myers JA; Widrick JJ; Eran A; Serafini PR; Alexander MS; Pletcher MT; Morris CA; Kunkel LM
    Hum Mol Genet; 2014 Apr; 23(7):1869-78. PubMed ID: 24234649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
    Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
    Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diaphragm muscle fibrosis involves changes in collagen organization with mechanical implications in Duchenne muscular dystrophy.
    Sahani R; Wallace CH; Jones BK; Blemker SS
    J Appl Physiol (1985); 2022 Mar; 132(3):653-672. PubMed ID: 35050792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skeletal muscle fibrosis in the mdx/utrn+/- mouse validates its suitability as a murine model of Duchenne muscular dystrophy.
    Gutpell KM; Hrinivich WT; Hoffman LM
    PLoS One; 2015; 10(1):e0117306. PubMed ID: 25607927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-Term Protective Effect of Human Dystrophin Expressing Chimeric (DEC) Cell Therapy on Amelioration of Function of Cardiac, Respiratory and Skeletal Muscles in Duchenne Muscular Dystrophy.
    Siemionow M; Langa P; Brodowska S; Kozlowska K; Zalants K; Budzynska K; Heydemann A
    Stem Cell Rev Rep; 2022 Dec; 18(8):2872-2892. PubMed ID: 35590083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of ultrasonography for non-invasive assessment of diaphragm function in muscular dystrophy.
    Whitehead NP; Bible KL; Kim MJ; Odom GL; Adams ME; Froehner SC
    J Physiol; 2016 Dec; 594(24):7215-7227. PubMed ID: 27570057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inspiratory pressure-generating capacity is preserved during ventilatory and non-ventilatory behaviours in young dystrophic mdx mice despite profound diaphragm muscle weakness.
    Burns DP; Murphy KH; Lucking EF; O'Halloran KD
    J Physiol; 2019 Feb; 597(3):831-848. PubMed ID: 30570134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Force and power output of diaphragm muscle strips from mdx and control mice after clenbuterol treatment.
    Lynch GS; Hinkle RT; Faulkner JA
    Neuromuscul Disord; 2001 Mar; 11(2):192-6. PubMed ID: 11257477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contractile efficiency of dystrophic mdx mouse muscle: in vivo and ex vivo assessment of adaptation to exercise of functional end points.
    Capogrosso RF; Mantuano P; Cozzoli A; Sanarica F; Massari AM; Conte E; Fonzino A; Giustino A; Rolland JF; Quaranta A; De Bellis M; Camerino GM; Grange RW; De Luca A
    J Appl Physiol (1985); 2017 Apr; 122(4):828-843. PubMed ID: 28057817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Respiratory characterization of a humanized Duchenne muscular dystrophy mouse model.
    Roger AL; Biswas DD; Huston ML; Le D; Bailey AM; Pucci LA; Shi Y; Robinson-Hamm J; Gersbach CA; ElMallah MK
    Respir Physiol Neurobiol; 2024 Aug; 326():104282. PubMed ID: 38782084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in calsequestrin, TNF-α, TGF-β and MyoD levels during the progression of skeletal muscle dystrophy in mdx mice: a comparative analysis of the quadriceps, diaphragm and intrinsic laryngeal muscles.
    Barros Maranhão J; de Oliveira Moreira D; Maurício AF; de Carvalho SC; Ferretti R; Pereira JA; Santo Neto H; Marques MJ
    Int J Exp Pathol; 2015 Oct; 96(5):285-93. PubMed ID: 26515458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensorimotor control of breathing in the mdx mouse model of Duchenne muscular dystrophy.
    Burns DP; Roy A; Lucking EF; McDonald FB; Gray S; Wilson RJ; Edge D; O'Halloran KD
    J Physiol; 2017 Nov; 595(21):6653-6672. PubMed ID: 28952155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defects in mitochondrial localization and ATP synthesis in the mdx mouse model of Duchenne muscular dystrophy are not alleviated by PDE5 inhibition.
    Percival JM; Siegel MP; Knowels G; Marcinek DJ
    Hum Mol Genet; 2013 Jan; 22(1):153-67. PubMed ID: 23049075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.